Vertex Pharmaceuticals · 1 day ago
Senior Manager, Third-Party Risk Management (TPRM)
Boston, MA
Full-time
Hybrid
Mid, Senior Level
$126K/yr - $190K/yr
5+ years expVertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation. The Senior Manager, Third-Party Risk Management (TPRM) will oversee the operational processes of the TPRM program, manage day-to-day operations, and engage with stakeholders to ensure effective risk management practices are in place.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Serve as the SME for TPRM operational processes, providing guidance and support to stakeholders across the organization
Manage the day-to-day operations of the TPRM program, ensuring efficient execution of processes and adherence to timelines
Support the use and maintenance of TPRM tools (e.g., ProcessUnity, Archer, RiskConnect), ensuring data accuracy and system optimization
Track and drive the resolution of findings and issues identified during third-party risk assessments
Support root cause analysis and corrective actions for third-party risk incidents to prevent recurrence
Partner with owners of Vertex's risk lanes (Operational, Financial, Regulatory, Structural) to facilitate the execution and tracking of TPRM risk assessments
Develop and maintain risk metrics, dashboards, and reports to provide visibility into TPRM activities and outcomes
Provide excellent user support to business owners, risk subject matter experts (SMEs), and other stakeholders involved in the TPRM process
Act as a liaison between vendors and business owners, triaging questions, facilitating communication, and ensuring timely resolution of issues
Collaborate with business owners to integrate TPRM requirements into vendor management processes
Support the development and delivery of training materials and workshops to enhance awareness and adoption of TPRM policies and processes
Assist in preparing materials for governance forums, including reporting, key metrics, and summaries
Ensure compliance with internal policies, regulatory requirements, and industry standards
Stay updated on changes in regulatory requirements and industry best practices to ensure the TPRM program remains current and effective
Qualification
Required
Bachelor's degree in Business, Finance, Risk Management, or a related field
5–7 years of experience in third-party risk management, sourcing, or compliance, preferably in a regulated industry
Hands-on experience with TPRM tools such as ProcessUnity, Archer, RiskConnect, or similar platforms
Strong organizational and communication skills, with a focus on stakeholder engagement and user support
Proven ability to manage operational processes and track issue resolution
Familiarity with third-party risk management policies, tools, and processes
Experience in collaborating with business owners and vendors to address and resolve inquiries
Proficiency in Microsoft Office and other relevant tools
Preferred
Experience in biopharma, biotech, or a related field is preferred but not mandatory
Benefits
Medical, dental and vision benefits
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
Educational assistance programs including student loan repayment
A generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
5001-10000 employees
H1B Sponsorship
Vertex Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (188)
2024 (150)
2023 (111)
2022 (164)
2021 (112)
2020 (80)
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Reshma Kewalramani
CEO and President
Nina Devlin
Senior Vice President, Chief Communications Officer
Recent News
2026-01-05
2026-01-05
Company data provided by crunchbase